Comparative Effectiveness of Psoriasis Treatments on Systemic Inflammation

Clinical Trial ID NCT02330380

PubWeight™ 0.00^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02330380

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION).	Br J Dermatol	2007	2.85
2	Comparative effectiveness of commonly used systemic treatments or phototherapy for moderate to severe plaque psoriasis in the clinical practice setting.	Arch Dermatol	2012	2.19
3	Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis.	N Engl J Med	2003	2.12
4	Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot study.	Arch Dermatol	2011	1.88
5	Methotrexate vs. ciclosporin in psoriasis: effectiveness, quality of life and safety. A randomized controlled trial.	Br J Dermatol	2007	1.03
6	Comparison of effectiveness and safety of infliximab, etanercept, and adalimumab in psoriatic arthritis patients who experienced an inadequate response to previous disease-modifying antirheumatic drugs.	Clin Rheumatol	2010	0.97
7	Comparative effects of biological therapies on the severity of skin symptoms and health-related quality of life in patients with plaque-type psoriasis: a meta-analysis.	Curr Med Res Opin	2008	0.86
8	Methotrexate versus traditional Chinese medicine in psoriasis: a randomized, placebo-controlled trial to determine efficacy, safety and quality of life.	Clin Exp Dermatol	2010	0.77
9	A cost-effectiveness comparison of liquor carbonis distillate solution and calcipotriol cream in the treatment of moderate chronic plaque psoriasis.	Arch Dermatol	2010	0.75